330 related articles for article (PubMed ID: 10611317)
21. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.
Strasser A; Harris AW; Cory S
Cell; 1991 Nov; 67(5):889-99. PubMed ID: 1959134
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
23. A functional analysis of protooncogene Vav's role in adult human hematopoiesis.
Luger SM; Ratajczak J; Ratajczak MZ; Kuczynski WI; DiPaola RS; Ngo W; Clevenger CV; Gewirtz AM
Blood; 1996 Feb; 87(4):1326-34. PubMed ID: 8608221
[TBL] [Abstract][Full Text] [Related]
24. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
Cory S; Harris AW; Strasser A
Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):289-95. PubMed ID: 7846127
[TBL] [Abstract][Full Text] [Related]
25. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
26. AlphaIIb integrin expression during development of the murine hemopoietic system.
Corbel C; Salaün J
Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
[TBL] [Abstract][Full Text] [Related]
27. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
[TBL] [Abstract][Full Text] [Related]
28. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo.
Inoue A; Seidel MG; Wu W; Kamizono S; Ferrando AA; Bronson RT; Iwasaki H; Akashi K; Morimoto A; Hitzler JK; Pestina TI; Jackson CW; Tanaka R; Chong MJ; McKinnon PJ; Inukai T; Grosveld GC; Look AT
Cancer Cell; 2002 Oct; 2(4):279-88. PubMed ID: 12398892
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
[TBL] [Abstract][Full Text] [Related]
30. c-fos expression interferes with thymus development in transgenic mice.
Rüther U; Müller W; Sumida T; Tokuhisa T; Rajewsky K; Wagner EF
Cell; 1988 Jun; 53(6):847-56. PubMed ID: 3133119
[TBL] [Abstract][Full Text] [Related]
31. Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.
Almarza E; Segovia JC; Guenechea G; Gómez SG; Ramírez A; Bueren JA
Exp Hematol; 2004 Apr; 32(4):360-4. PubMed ID: 15050746
[TBL] [Abstract][Full Text] [Related]
32. Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.
Strasser A; Elefanty AG; Harris AW; Cory S
EMBO J; 1996 Aug; 15(15):3823-34. PubMed ID: 8670887
[TBL] [Abstract][Full Text] [Related]
33. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
McKenna HJ; Stocking KL; Miller RE; Brasel K; De Smedt T; Maraskovsky E; Maliszewski CR; Lynch DH; Smith J; Pulendran B; Roux ER; Teepe M; Lyman SD; Peschon JJ
Blood; 2000 Jun; 95(11):3489-97. PubMed ID: 10828034
[TBL] [Abstract][Full Text] [Related]
34. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers.
Rahman ZS; Manser T
J Immunol; 2004 Nov; 173(10):6179-88. PubMed ID: 15528355
[TBL] [Abstract][Full Text] [Related]
35. Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
Bird GA; Polsky A; Estes P; Hanlon T; Hamilton H; Morton JJ; Gutman J; Jimeno A; Turner BC; Refaeli Y
PLoS One; 2014; 9(8):e105525. PubMed ID: 25170611
[TBL] [Abstract][Full Text] [Related]
36. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
37. Role of members of the Wnt gene family in human hematopoiesis.
Van Den Berg DJ; Sharma AK; Bruno E; Hoffman R
Blood; 1998 Nov; 92(9):3189-202. PubMed ID: 9787155
[TBL] [Abstract][Full Text] [Related]
38. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro.
Zmuidzinas A; Fischer KD; Lira SA; Forrester L; Bryant S; Bernstein A; Barbacid M
EMBO J; 1995 Jan; 14(1):1-11. PubMed ID: 7828581
[TBL] [Abstract][Full Text] [Related]
39. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
40. Lineage-instructive function of C/EBPα in multipotent hematopoietic cells and early thymic progenitors.
Wölfler A; Danen-van Oorschot AA; Haanstra JR; Valkhof M; Bodner C; Vroegindeweij E; van Strien P; Novak A; Cupedo T; Touw IP
Blood; 2010 Nov; 116(20):4116-25. PubMed ID: 20807890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
